Startups
Ogenix is the manufacturer of EPIFLO, an FDA cleared, 3 ounce, 24/7 oxygen therapy which effectively treats many chronic wounds such as diabetic foot ulcers, venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns and many others.
Overview
Location
United States, Ohio, Beachwood
Employees
11-50
Founded date
2006
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 29, 2011 | Ohio’s investor tax credit: Who’s using it (and who isn’t) | What’s more, while $1.5 million is the maximum investment amount that can be raised with the tax credit, only 80 companies have even raised $750,000 in equity toward the credit. Only 11 companies have raised essentially the maximum. In life... |
| Oxygen therapy device for wound healing gets FDA warning letter | Ogenix has received a warning letter from the U.S. Food and Drug Administration related to its Epiflo oxygen therapy medical device for wound healing. The FDA’s warning letter details six specific violations uncovered during an inspection o... | |
| Ohio’s investor tax credit: Who’s using it (and who isn’t) | People love talking about the value of getting investor tax credits. Companies seem to love applying for tax credits. Using the investor tax credit? That’s different. A total of 590 companies have been approved for Ohio’s Technology Investm... |
Reviews 0
FAQ about Ogenix
When was Ogenix founded?
Ogenix was founded in 2006.
What has the press written about Ogenix?
Parsers VC has collected 4 articles mentioning Ogenix, among them “Ohio’s investor tax credit: Who’s using it (and who isn’t)” (Sep 29, 2011) and “Oxygen therapy device for wound healing gets FDA warning letter”.
Is Ogenix still active?
Yes, Ogenix is active; its latest activity on Parsers VC dates from Apr 4, 2012.